Chronic care platform Dario Health expanded its cardiometabolic platform with Dario Women, a new program supporting women through perimenopause and menopause.
With one in three menopausal women developing metabolic syndrome, the program addresses weight changes, sleep disruptions, metabolic shifts, and other symptoms that can increase cardiometabolic risk.
The launch follows Dario Sleep, a program linking obstructive sleep apnea to cardiometabolic disease. Powered by more than 13 billion proprietary longitudinal healthcare data points, Dario’s AI platform combines digital engagement, behavioral coaching, and clinical care to improve outcomes while lowering costs.
“Women’s health and sleep represent significant opportunities to improve cardiometabolic outcomes while expanding the value we deliver to employers, health plans, and members,” said Erez Raphael, Chief Executive Officer of Dario. “As we continue adding clinical capabilities to our platform, we strengthen our ability to support members throughout their healthcare journey while creating new opportunities to grow revenue through healthcare services that extend beyond digital engagement.”
Following a clinical assessment, Dario Women’s members receive individualized plans, which include AI-powered insights, personalized coaching, provider-backed clinical care, and hormone replacement therapy when medically appropriate.
